TIL Q1 2024 Earnings — Instil Bio, Inc. Revenue & Financial Results | Market Cap Arena

TILInstil Bio, Inc.

$62M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$993,000

Operating Income

-$20M

Net Income

-$24M

EPS (Diluted)

$-3.74

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$306M

Total Liabilities

$100M

Stockholders' Equity

$206M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$993,000	$0	—
Operating Income	-$20M	-$58M	+66.3%
Net Income	-$24M	-$57M	+57.4%